chrisvoncsefalvay/vaers-outcomes huggingface dataset:
after the vaccine was given the injection site was red, and swollen.; after the vaccine was given the injection site was red, and swollen.; soft tissue swelling; multiple cystic growths with no need to drain the left thigh.; This spontaneous report has been received from a physician, via company representative, referring to a 12-months-old patient of unspecified gender. Information regarding the patient's pertinent medical history, concomitant medications, past drug reactions or allergies was unknown by the reporter.  On 25-JUN-2021, the patient was vaccinated with a one (1) time dose of Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (rHA) (M-M-R II) that was administered on the left tight (exact dose and route of administration were not provided; lot number T013728 that has been verified to be valid with an expiration date reported and established as 21-APR-2022) as active immunization for the prevention of measles, mumps, and rubella (prophylaxis). On that same date, right after the vaccine was given the injection site was red and swollen (vaccination site erythema and vaccination site swelling).   On an unspecified date in 2021, the patient developed soft tissue swelling with multiple cystic growths (cyst) that were noted on a visit to emergency room (ER) on 09-JUL-2021 (reported as "2 weeks after the injection"). It was reported that it was no needed to drain the left thigh. It was stated that patient has been followed up by a pediatric surgeon.  It was reported that no treatment was given for the events. It was unknown by the reporter if any lab diagnostics or studies were performed. It was stated that this patient experienced the same effects as another baby patient who also was vaccinated with a Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (rHA) (M-M-R II) that had the same lot number (reported in case #2108USA001689).   The outcome of the events at the time of this report was reported as unknown. The causality assessment between the suspect vaccine with all the events was not provided.  This is one of two reports reported by the same reporter.; Sender's Comments:  US-009507513-2108USA001689:
Case previously recorded as MA2009-6270. Initial case report received from a health care professional on 25 NOV 2009. Twenty children younger than 04 years of age received FLUVIRIN intramuscular inadvertent administration on an unknown date. No adverse events reported. Medical history: Not reported. Reference no. NA09-008851.
G4P1 prior uncomplicated pregnancy 35 +1 weeks pregnant  EDD 27 Feb. That night I went to drink and liquid came out my mouth spontaneously,  my left side of face had lost normal wrinkles on forehead, eyebrow wouldn't lift, eyelid wouldn't blink, cheek couldn't puff, lips didn't smile. Next day (1) slight cheek numbness noted- resolved Day3 . Day 2 slight difficulty articulating words. Night 3 intermittent sharp outer ear and mastoid area pain duration 30min and at different times intermittent pulsatile heartbeat and whistling sound 10 min or less.  Day 4 & 6 notable improvements in cheek ability to puff- not fully resolved though. Day 5 eyelid movement - not fully resolved though.  Day 6: less difficulty articulating. Day 1: Spoke to OB office nurse- offered steroids which I declined & spoke to PCP recommended go to ED, which I declined, I'm a family physician and had otherwise normal Cranial nerve testing and no other neurological changes- seems fully consistent with Bell's palsy.  Day 3 had co-worker physician use otoscope - normal exam bilaterally.
large, swollen hard red lump at injection site. Ran fever of 100.6 for a day and a half.
1 hr p/injecr resident exp a runny nose & pain over mid chest on lt side w/o radiation of lt arm lasting 10 mins; denied SOB;
Fever of 100.2F; Headache; Body ache; A spontaneous report was received from a consumer concerning a 74-years- female patient, received Moderna's COVID-19 vaccine (mRNA-1273 and experienced pyrexia/ fever of 100.2F, Headache and bodyache/ myalgia.  The patient's medical history was not reported. No relevant concomitant medication were reported  On 12 feb 2021 approximately 6 days prior to the onset of events the patient received their first planned dose of mRNA-1273 (Lot number: 030M20A) via unknown route in left arm for prophylaxis of COVID-19 infection.   On 15 feb 2021, approximately 6 days prior to receiving  mRNA-1273  the patient experienced pyrexia/ fever of 100.2F, Headache and Myalgia. Treatment for the events included paracetamol  Action taken with mRNA-1273 in response to the event was unknown    Outcome of the events, Pyrexia/ fever of 100.2F, Headche and myalgia were resolved
The patient was feeling different the night after getting the vaccines. According to the patient she experienced blisters (watery and bloody blisters) the next day after getting the vaccines for 2 days. Also she experience fever, cough, hives and itching for 2 days.
FALL/SHE FELL OVER AGAIN; UPON DISCHARGE WENT HOME WITH WALKER/SENT HER HOME WITH A WALKER; HAVING TROUBLE WITH HER DAILY LIFE; RED POLKADOTS ON HANDS; DRY SKIN; SOMETHING IN THROAT/RASPY THROAT; LEGS  COLLAPSED; HER LEGS TURNED TO RUBBER; SAT DOWN HARD ON HER RIGHT ASS; HIT HEAD ON THE PAVEMENT; IT HURT; GOT UP DURING THE NIGHT; This spontaneous report received from a patient concerned a 68 year old other race female. The patient's height, and weight were not reported.  The patient's past medical history included has broken 3 bones in the top of the foot, stroke, and shattered her shoulders and arm, and concurrent conditions included seizure, hydrochlorothiazide allergy, and penicillin allergy. The patient taking blood pressure pills and pills for seizures (unspecified). The patient received Covid-19 (suspension for injection, route of admin not reported, batch number: 1808978, expiry: UNKNOWN) 1 total dose, administered on 24-MAR-2021 for prophylactic vaccination. No concomitant medications were reported.  On 24-MAR-2021, the patient hurts. Then the patient went home; and went to store for picked up some groceries. On the way back to car the patient's legs turned to rubber and she sat down. Her legs collapsed and sat on ass hit head on the pavement. On 25-MAR-2021 the patient got up during the night and same things happened again and she fell over again and spent the night on the floor and admitted to hospital (dates unspecified) for 4 days and the patient received blood thinner shots (unspecified) in her stomach. The patient discharged from hospital (dates unspecified) with walker. On an unspecified dates the patient had all kinds of tests and all came back normal. On an unknown date the patient having trouble with her daily life. The patient had a physical therapy and occupational therapy for a month. On 30-MAR-2021, the patient experienced dry skin and something in throat/raspy throat. On an unknown date the patient had red polkadots on hands.  The action taken with covid-19 vaccine was not applicable. On an unknown date the patient was recovered from fall/she fell over again, and not recovered from dry skin, and something in throat/raspy throat and the outcome for and the outcome of red polkadots on hands, her legs turned to rubber, sat down hard on her right ass, legs collapsed, hit head on the pavement, got up during the night, it hurt, upon discharge went home with walker/sent her home with a walker and having trouble with her daily life was not reported  This report was serious (Hospitalization Caused / Prolonged). FALL/SHE FELL OVER AGAIN. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).
Day 1: Within 5 hours, headache and stiff shoulder. Took Tylenol. Within 9 hours, headache had intensified and experienced a few waves of overwhelm from it. Took Ibuprofen and went to bed. .  Day 2: Headache had eased up by morning; shoulder discomfort still prevalent. Injection site sore with red circle, raised and warm.   Day 3: Stiff/painful neck. Circle on arm still red, raised, warm--about 3.5 inches in diameter.  Day 4: Stiff neck impeding normal activities. By end of day, arm finally looks to be improving and is tingly/itchy, but neck pain is radiating into throat.  Day 5: Injection site looks normal, still a little tingly. Neck persists, though no longer radiating--just still and painful.  Day 6: Neck persists.  Day 7: Neck persists. Intestinal distress in evening.  Day 10: finally some improvement in neck!  Day 11 (today): didn't even think about my neck until mid-day--much improved.
Site: Redness at Injection Site-Mild, Site: Swelling at Injection Site-Mild, Additional Details: patient referred to urgent care for possible cellulitis or skin infection
Per pt, he's been having  headache and heart palpitations ever since he received the vaccine.
10/19/2022 A little tightness in chest causing uncomfortable breathing.  That evening I got a headache and was very tired.  10/20, left arm was sore and swollen.  Headache in the back of the head.  Very fatigued.  10/21, symptoms were the same, arm was red and swollen.  Pain across both shoulders and up the back of the neck.  10/22 Fatigue was still very strong.  Could not turn head due to pain in the neck.  Felt like a crook in the neck.  10/23 Noticed swelling lymph not under left collarbone.  10/24 saw the doctor about this situation.  Doctor did recommend taking NSAIDS for pain and monitor this situation.   10/27 Some slight pain in back of the neck up to the left side ear.
What if I get a rash after receiving Shingrix; This case was reported by a consumer via interactive digital media and described the occurrence of rash in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced rash. On an unknown date, the outcome of the rash was unknown.   It was unknown if the reporter considered the rash to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The age group was not reported but it was selected as adult as per the vaccine indication. The patient asked what if the patient got a rash after receiving Shingrix.
Headache, fever (99.8 - 101.5), body aches, swollen at site of shot, arm turned red at shot and then whole arm.  Didn't treat as instructions said consult Dr. first and he was unavailable.  Fever and body aches ended ~7pm on 4/12.  Headache ended sometime in the early morning on 4/13.  Short of breath and dizzy still today 4/13 although not as bad as yesterday.
7 days after vaccination I woke up with abdominal pain, right below my rib cage. It felt like I had swallowed a rock. Over 48 hours, the ache stayed the same but a headache came on, and then a very low grade fever, under 100. It wasn?t severe but it was enough to keep me from eating or sleeping for 48 hours. Motrin seemed to help the abdominal pain. Then I recovered.
COLD; CHEST TIGHTNESS; NAUSEA; FEVER; INJECTION SITE HURT ALOT; REALLY BAD HEADACHE; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 1805020 expiry: UNKNOWN) dose was not reported, administered on 13-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On MAR-2021, the subject experienced cold. On MAR-2021, the subject experienced chest tightness. On MAR-2021, the subject experienced nausea. On MAR-2021, the subject experienced fever. On MAR-2021, the subject experienced injection site hurt alot. On MAR-2021, the subject experienced really bad headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the cold, fever, chest tightness, injection site hurt alot, really bad headache and nausea was not reported. This report was non-serious.
Seborrheic Dermatitis; Pinkish area of my face after doses/Pink patches on face, hairline; Hives on neck; This spontaneous case was reported by a nurse and describes the occurrence of SEBORRHOEIC DERMATITIS (Seborrheic Dermatitis), SKIN DISCOLOURATION (Pinkish area of my face after doses/Pink patches on face, hairline) and URTICARIA (Hives on neck) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 006D21A, 032L20A and 032L20A) for COVID-19 vaccination.     Concurrent medical conditions included Perimenopause.   On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 11-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced SEBORRHOEIC DERMATITIS (Seborrheic Dermatitis), SKIN DISCOLOURATION (Pinkish area of my face after doses/Pink patches on face, hairline) and URTICARIA (Hives on neck). At the time of the report, SEBORRHOEIC DERMATITIS (Seborrheic Dermatitis), SKIN DISCOLOURATION (Pinkish area of my face after doses/Pink patches on face, hairline) and URTICARIA (Hives on neck) was resolving.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Laboratory test: it came back seborrheic dermatitis it came back Seborrheic Dermatitis.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered SEBORRHOEIC DERMATITIS (Seborrheic Dermatitis), SKIN DISCOLOURATION (Pinkish area of my face after doses/Pink patches on face, hairline) and URTICARIA (Hives on neck) to be related.    No concomitant medications were reported.  The patient undergone a lot of hormonal changes.  It was reported that, the events got much worsen after the booster dose.  It was also reported that, the immune system and the vaccine caused the event.  The patient used Topical Roslumilast Foam (ARQ-154) (instead of the placebo) as a treatment medication which was used in COPD in a pill form.   This case was linked to MOD-2022-516171 (Patient Link).
4/19-4/22: Chills, aches  4/19-present (4/23): swelling, lymphadenopathy near vaccination site, night sweats
constant migraine headaches daily since receiving the booster.  Most time I awake in the morning with headaches and need to take pain reliever 2-3 a day. Same occurrence when I took the 2nd vaccine shot in July 2021 which headaches lasted for over a month.
Nausea; Headache; Chills; This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA (Nausea), HEADACHE (Headache) and CHILLS (Chills) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012AZ1A and 042LZ0A) for COVID-19 vaccination.     No Medical History information was reported.   On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 05-Mar-2021, the patient experienced NAUSEA (Nausea), HEADACHE (Headache) and CHILLS (Chills). At the time of the report, NAUSEA (Nausea), HEADACHE (Headache) and CHILLS (Chills) had resolved.            Patient did not experience any side effects with first dose. After second dose symptoms started after 24 hours &  lasted for at least 24 hours. Patient is not on any medication.  Treatment was not given for the side effects.
12/11/2012 vomited x 1, fatigued, fever and chills. Left arm red at injection site. 12/12/2012 vomited x 1, fatigued, fever and chills.
Patient returned to clinic today for wellchild visit and to get 6 month vaccines. Small, round, red area noted on left thigh; mother states has been there since patient received last vaccines on April 13th, 2021, otherwise patient has no other issues.
I revived the shot at 8:42 after shot I got a little light headed, set rested for a minute, left clinic got home started feeling sick to my stomach, laid down, slept for 2 hours got up ate dinner at 6:30 - 7:00 pm went to bed at 10:00 pm stared feeling aches and chills and dizzy took Ibuprofen around 6:00am couldn?t sleep, got up at 7:30 started feeling better at 8:00am on 8-16-2019. Still feeling shaky.
After receiving the shot I got body aches, hot/cold flashes, numbness of my left arm and foot, and other typical symptoms.  After a week I experienced swollen lymph nodes as well as a myriad of other symptoms.  At the time of writing symptoms are continuing.
Terrible arm soreness started 2hr after injection and lasted for abt 24hours. Then next 24hours was sore but not bad.  Got fatigued the day of shot. Took afternoon nap and just went to bed early.  Felt fine from Sunday to Wednesday.  Developed chills on Wednesday.  Still have today.  No fevers though.
Anaphylaxis: scratchy throat, tight chest, wheezing and SOB, overall discomfort sensation:  Treated with albuterol MDI on own, then given Neb of albuterol and Benadryl 25 mg IM x1.  Watched for 3 hrs.  Given Prednisone Taper the next day as still had sx overnight and into the next day.12/9/2009 PCP records for 11/2/2009, c/o's chest tightness, SOB, scratchy throat, tx: Albuterol, Benadryl and prednisone .
Stroke; A spontaneous report was received from a consumer concerning her husband, a 75 years old, male patient who received Moderna (mRNA-1273) vaccine and experienced Stroke (Cerebrovascular accident).  The patient's medical history was not provided. Concomitant products known to have been used by the patient, within two weeks prior to the event, included: prefervifion.  On 14-Feb-2021, prior to the onset of the symptoms, the patient received their first of two planned doses of mRNA-1273 (Batch number: 031M20A)intramuscularly for prophylaxis of COVID-19 infection.   On 1-Mar-2021, the patient had a stroke and was hospitalized on the same day. The patient is still hospitalized. No laboratory details were provided.  On 14 Mar 2021, the patient has their second shot scheduled.  Treatment information provided by the reporter included: Aspirin, prolix, cleft, lovenox.  Action taken with mRNA-1273 in response to the event was unknown  The outcome of the event, Stroke was considered Not resolved.; Reporter's Comments: Very limited information regarding this event has been provided at this time.  Further information has been requested.
Patient reported to pharmacy for her second covid 19 moderna vaccine dose.  She reported no adverse reaction to her first dose.  pharmacist reviewed patient's forms and asked patient if she was allergic to anything, patient reported amoxicillin.  Technician then gave the patient her second dose in the patient's left deltoid muscle.  Patient was observed for 15 minutes and then patient left after stating she felt fine.  At almost 45 minutes later when she finished shopping, she contacted the pharmacy and stated her left arm at the injection site was itching.  Instructed patient to use a cold compress and to get some liquid benadryl.  Asked patient if she was having trouble breathing or throat closure and patient stated no.  Told patient to go to ER if started to have trouble breathing and throat closure/swelling.  Instructed patient to have someone keep an eye on her throughout the night.  contacted patient at around 8 Pm to check on her and she stated that she still had slight itchiness, but still no trouble breathing or swollen throat.  Patient stated benadryl work.
This report describes injection site swelling and redness in a 17 month old male who received DTaP. Concomitant vaccines (dates unspecified) were inactivated poliomyelitis vaccine, and  haemophilus influenza B vaccine. On 03/0101, the vaccinee received his second dose of DTaP. Post-vaccination on 03/01/01, the vaccinee experienced redness and swelling at the injection site. He was treated with ceftriaxone sodium IM 500 mg per day for three days from 03/02/01 to 04/04/01 and diphenhydramine hydrochloride 5cc every six hrs from 03/02/01 to 03/04/01. DTaP was stopped due to adverse events, and the dosing schedule of DTaP was interrupted. The vaccinee recovered w/out complications on 03/02/01. As of 03/06/01, the outcome of the adverse events was recovered.
Information has been received from a physician concerning a adult patient who in August 2007, was vaccinated with a dose of varicella virus vaccine live (Oka/Merck). The patient inadvertently received varicella virus vaccine live (Oka/Merck) instead of zoster vaccine live (Oka/Merck) (MSD) due to human error. A product quality complaint was not involved. Follow-up information was received on 20-SEP-2007 via a telephone call. The physician reported the patient did not experience any adverse event and "is doing fine". This is one of several reports from the same source. Additional information has been requested.
lips are showing visible fencing technique/lumpiness in lips; This spontaneous case was reported by a nurse and describes the occurrence of LIP SWELLING (lips are showing visible fencing technique/lumpiness in lips) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Hypothyroidism since an unknown date. Previously administered products included for Diphtheria immunisation: TDAP (Immunization was also used for PERTUSSIS immunization and TETANUS immunization) on 14-Jul-2021. Concurrent medical conditions included Dermal filler injection (Patient was injected with Restylane Kysse) since 06-May-2021. Concomitant products included HYALURONIC ACID, LIDOCAINE HYDROCHLORIDE (RESTYLANE LIDOCAINE) from 06-May-2021 to an unknown date for Lip cosmetic procedure.   On 29-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced LIP SWELLING (lips are showing visible fencing technique/lumpiness in lips). At the time of the report, LIP SWELLING (lips are showing visible fencing technique/lumpiness in lips) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter. Treatment information was not provided.